Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Protein Misfolding and Human Disease

6/8/2011

Benjamin Schuler, Ph.D., Professor of Biochemistry, University of Zurich

A large number of illnesses stem from misfolded proteins. Researchers at the University of Zurich have now studied protein misfolding using a special spectroscopic technique. Misfolding, as they report in a recent issue of Nature, is more frequent if the sequence of the amino acids in the neighboring protein domains is very similar.


During this week’s podcast one of the Nature paper’s authors, Dr. Benjamin Schuler, provides specific examples of diseases that result from problems in protein folding and discusses how he and his team went about investigating the circumstances under which protein misfolding occurs. He describes the type of technology the group used to carry out the research project and reveals the team’s major findings.


Dr. Schuler also talks about the clinical implications of the work on protein misfolding and highlights future laboratory projects designed to take this research to the next level.

Ben Schuler joined the department of Chemistry at the University of Zurich in 2004 and was promoted to full professor of biochemistry in September 2009. He investigates the folding, misfolding, and dynamics of proteins using a close combination of biochemical and spectroscopic methods, in particular single-molecule fluorescence. Dr. Schuler studied biochemistry at the University of Regensburg, Germany, and at the University of Kent, U.K. He received his Ph.D. in physical biochemistry from the University of Regensburg in 1998. He did his postdoctoral research in biophysics at the NIH. Supported by the Emmy Noether Program of the Deutsche Forschungsgemeinschaft, Ben Schuler then headed an independent research group at the University of Potsdam in Germany.


Related content

GEN News Highlights

MORE RELATED GEN NEWS HIGHLIGHTS

Insight & Intelligence™

MORE RELATED INSIGHT & INTELLIGENCE™

GEN Articles

MORE RELATED GEN ARTICLES

Webinars

MORE RELATED WEBINARS

Best of the Web

MORE RELATED BEST OF THE WEB

Subscription center

BACK TO TOP

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
 

All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

GEN webinars

« View All Webinars »

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll
« More »     « View Results »     « Poll Archive »